Évaluation des marqueurs p63 et p504s dans le diagnostic du cancer de prostate
Authors:
- Vincent MoliniéVMVincent Molinié
- Annick VieillefondAVAnnick Vieillefond
- Jean-François MichielsJMJean-François Michiels
- 1 October 2008
- journal article
- abstracts
- Published by Elsevier in Annales de Pathologie
- Vol. 28 (5) , 417-423
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Abundant expression of AMACR in many distinct tumour typesPathology, 2006
- Sensitivity of P504S/??-Methylacyl-CoA Racemase (AMACR) Immunohistochemistry for the Detection of Prostate Carcinoma on Stored Needle BiopsiesApplied Immunohistochemistry & Molecular Morphology, 2006
- Alpha-methyl CoA racemase expression in renal cell carcinomasHuman Pathology, 2006
- Diagnostic utility of a p63/α‐methyl coenzyme A racemase (p504s) cocktail in ambiguous lesions of the prostate upon needle biopsyBJU International, 2006
- Clinical interpretation of prostate biopsy reportsUrology, 2006
- p63/AMACR Antibody Cocktail Restaining of Prostate Needle Biopsy Tissues After Transfer to Charged SlidesAmerican Journal of Clinical Pathology, 2005
- Immunohistochemistry in diagnostic surgical pathology of the prostateSeminars in Diagnostic Pathology, 2005
- Cancer de la prostate. Épidémiologie. Facteurs de risques. AnatomopathologieAnnales d'Urologie, 2004
- Diagnostic utility of a p63/α-methyl-CoA-racemase (p504s) cocktail in atypical foci in the prostateLaboratory Investigation, 2004
- Pathological and molecular aspects of prostate cancerThe Lancet, 2003